Curaleaf (OTCMKTS:CURLF) Shares Gap Down – What’s Next?

Curaleaf Holdings, Inc. (OTCMKTS:CURLF)’s share price gapped down before the market opened on Wednesday . The stock had previously closed at $9.96, but opened at $9.28. Curaleaf shares last traded at $9.8868, with a volume of 5,224 shares traded.

Analysts Set New Price Targets

CURLF has been the topic of a number of recent research reports. Citigroup restated a “buy” rating on shares of Curaleaf in a report on Thursday, August 6th. Zacks Research raised shares of Curaleaf from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, July 14th. Three analysts have rated the stock with a Strong Buy rating and two have given a Buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Strong Buy”.

Curaleaf Stock Down 3.6%

The company has a current ratio of 1.52, a quick ratio of 0.73 and a debt-to-equity ratio of 1.06. The firm has a 50 day moving average price of $9.34 and a two-hundred day moving average price of $8.12. The firm has a market capitalization of $2.30 billion, a price-to-earnings ratio of -75.60 and a beta of 1.57.

Curaleaf (OTCMKTS:CURLF) last issued its earnings results on Wednesday, August 5th. The company reported $0.05 EPS for the quarter, beating analysts’ consensus estimates of ($0.20) by $0.25. The business had revenue of $340.10 million for the quarter, compared to the consensus estimate of $332.00 million. Curaleaf had a negative net margin of 2.62% and a negative return on equity of 0.88%. On average, equities analysts expect that Curaleaf Holdings, Inc. will post 0.01 earnings per share for the current fiscal year.

About Curaleaf

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.